Evaluation of the photon dose calculation accuracy in radiation therapy of malignant pleural mesothelioma

被引:5
|
作者
Mahmoudi, Golshan [1 ,2 ]
Farhood, Bagher [2 ]
Shokrani, Parvaneh [3 ]
Amouheidari, Alireza [4 ]
Atarod, Maryam [5 ]
机构
[1] Sabzevar Univ Med Sci, Dept Med Phys, Sabzevar, Iran
[2] Univ Tehran Med Sci, Sch Med, Dept Med Phys & Biomed Engn, Tehran, Iran
[3] Isfahan Univ Med Sci, Sch Med, Dept Med Phys, Esfahan, Iran
[4] Milad Hosp, Dept Radiat Oncol, Esfahan, Iran
[5] Shahrekord Univ Med Sci, Sch Med, Dept Med Phys, Shahrekord, Iran
关键词
EGSnrc Monte Carlo code; inhomogeneity; malignant pleural mesothelioma; radiation therapy; TiGRT; EXTERNAL-BEAM RADIOTHERAPY; TREATMENT PLANNING SYSTEMS; MONTE-CARLO; AIR CAVITIES; 6; MV; LUNG; EQUILIBRIUM; ALGORITHMS; SIMULATION; MEDIA;
D O I
10.4103/0973-1482.187284
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background: Photon dose distribution of malignant pleural mesothelioma (MPM) in matched photon-electron technique is influenced by media inhomogeneity, lateral electronic disequilibrium at interfaces and narrow field. These may influence the dose calculation accuracy, calculated by treatment planning systems (TPS). This study aimed to evaluate the dose calculation accuracy of TiGRT TPS in radiation therapy of MPM. Materials and Methods: 18 MV photon beams of ONCOR Siemens linear accelerator was simulated using EGSnrc Monte Carlo (MC) code. Data of four patients were used to compare TPS and MC results in different regions included: Open and in-field, under shied and out of field regions. Results: Compared to MC results, the TPS overestimated the pleura dose coverage (90% of prescribed dose) about 3-12 mm, and also it overestimated the dose in under the shielded regions of lung (4-74%). While the TPS underestimated the dose profile width about 1-16 mm in low dose region (<50% prescribed dose) as well as the out of field region dose (4-100%). Conclusions: Results showed that TPS underestimated the dose in out of field and overestimated the dose in under the shielded regions. Unlike MC measurements, TPS calculation showed adequate pleural dose coverage. Based on the results, MC calculation can be used in matched photon-electron beam radiation therapy of MPM to modify the TPS photon dose calculations in the presence of heterogeneity, interfaces, and shield in MPM radiotherapy.
引用
收藏
页码:1029 / 1035
页数:7
相关论文
共 50 条
  • [21] Hemithoracic radiation therapy after pleurectomy/decortication for malignant pleural mesothelioma
    Gupta, V
    Mychalczak, B
    Krug, L
    Flores, R
    Bains, M
    Rusch, VW
    Rosenzweig, KE
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2005, 63 (04): : 1045 - 1052
  • [22] Clinical outcomes of stereotactic body radiation therapy for malignant pleural mesothelioma
    Shin, Jacob Y.
    Offin, Michael
    Simone II, Charles B.
    Zhang, Zhigang
    Shepherd, Annemarie F.
    Wu, Abraham J.
    Shaverdian, Narek
    Gelblum, Daphna Y.
    Gomez, Daniel R.
    Sauter, Jennifer L.
    Ginsberg, Michelle S.
    Adusumilli, Prasad S.
    Rusch, Valerie W.
    Zauderer, Marjorie G.
    Rimner, Andreas
    RADIOTHERAPY AND ONCOLOGY, 2024, 191
  • [23] Extrapleural Pneumonectomy, Radiation Therapy, and Chemotherapy for Epithelioid Malignant Pleural Mesothelioma
    Okabe, K.
    Inokawa, H.
    Hayashi, M.
    Okita, R.
    Furukawa, M.
    Yamamoto, M.
    JOURNAL OF THORACIC ONCOLOGY, 2018, 13 (10) : S753 - S753
  • [24] Managing oligoprogressive malignant pleural mesothelioma with stereotactic body radiation therapy
    Barsky, Andrew R.
    Yegya-Raman, Nikhil
    Katz, Sharyn I.
    Simone, Charles B., II
    Cengel, Keith A.
    LUNG CANCER, 2021, 157 : 163 - 164
  • [25] Photodynamic Therapy for Malignant Pleural Mesothelioma
    Friedberg, Joseph S.
    JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK, 2012, 10 : S75 - S79
  • [26] Multimodality therapy for malignant pleural mesothelioma
    Sugarbaker, DJ
    Garcia, JP
    CHEST, 1997, 112 (04) : S272 - S275
  • [27] Trimodality Therapy for Malignant Pleural Mesothelioma
    Buduhan, Gordon
    Menon, Shekhar
    Aye, Ralph
    Louie, Brian
    Mehta, Vivek
    Vallieres, Eric
    ANNALS OF THORACIC SURGERY, 2009, 88 (03): : 870 - 876
  • [28] Gene therapy for malignant pleural mesothelioma
    Sterman, DH
    HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA, 2005, 19 (06) : 1147 - +
  • [29] Pemetrexed therapy for malignant pleural mesothelioma
    Puto, K
    Garey, JS
    ANNALS OF PHARMACOTHERAPY, 2005, 39 (04) : 678 - 683
  • [30] Multimodality therapy for malignant pleural mesothelioma
    Weder, Walter
    Opitz, Isabelle
    ANNALS OF CARDIOTHORACIC SURGERY, 2012, 1 (04) : 502 - 507